A pilot study evaluating response to induction chemotherapy with oxaliplatin, capecitabine and bevacizumab in patients with extensive peritoneal carcinomatosis of colorectal origin.

ABSTRACT: Primary end point will be the assessment of macroscopic and microscopic response. Primary endpoints: Het primaire objectief voor deze studie is:- Het onderzoeken van de response rate en de macroscopische en microscopische responskenmerken van neo-adjuvante chemotherapie in patiënten met peritoneale carcinomatose (PC) van colorectale oorsprong.

DISEASE(S): Induction Chemotherapy For Peritoneal Carcinomatosis Of Colorectal Cancer

PROVIDER: 2527556 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR